[ { "id": "asmd-xenpozyme", "title": "ASMD / Xenpozyme QSP v2.0", "short": "Adult and paediatric olipudase alfa ERT model for acid sphingomyelinase deficiency.", "area": "Rare disease \u00b7 Lysosomal storage", "tag": "NEW", "tier": "Open + Clinical", "status": "SBML v2.0 adult/paediatric available", "page": "models/asmd-xenpozyme.html", "features": [ "Residual ASM activity and sphingomyelin burden", "Olipudase alfa PK, tissue uptake and lysosomal delivery", "Lyso\u2011SM, ceramide, spleen, liver, DLCO and platelet endpoints", "Adult-to-paediatric dose-bridging and regimen optimisation" ], "free": [ "SBML v2.0 adult and paediatric files", "v0.2/v0.3 development SBML scaffold", "Selected CSV/JSON reports", "Figures and static artefact bundle" ], "paid": [ "Quarterly re-calibration against new ASCEND/OLE evidence", "Patient-level virtual twin extensions", "Regulatory V&V40 dossier and COU refinement", "Partner-specific dose and benefit-risk scenarios" ], "downloads": [ [ "Adult SBML v2.0", "../sbml/ASMD_Xenpozyme_QSP_v2_0_adult.xml" ], [ "Paediatric SBML v2.0", "../sbml/ASMD_Xenpozyme_QSP_v2_0_paediatric.xml" ], [ "Full ASMD v2 bundle", "../downloads/asmd_v2_full_bundle.zip" ], [ "Decision table CSV", "../data/asmd/ASMD_Xenpozyme_QSP_v2_0_decision_table.csv" ], [ "Model summary JSON", "../data/asmd/ASMD_Xenpozyme_QSP_v2_0_model_summary.json" ] ] }, { "id": "pompe-v2", "title": "Pompe QSP v2.0", "short": "ERT optimisation across LOPD, IOPD CRIM+ and IOPD CRIM\u2212 populations.", "area": "Rare disease \u00b7 Glycogen storage", "tag": "OPEN", "tier": "Open + Clinical", "status": "SBML and bundle available", "page": "models/pompe-v2.html", "features": [ "Avalglucosidase and cipaglucosidase + miglustat regimens", "CRIM-status stratification and ITI benefit", "Hex4, 6MWT and FVC endpoint mapping", "ASME V&V40-style dossier" ], "free": [ "Model page and publication description", "Selected SBML / bundle artefacts", "Decision table CSV" ], "paid": [ "Clinical layer", "Quarterly update and partner scenarios" ] }, { "id": "car-t", "title": "CAR\u2011T QSP resistance model", "short": "Mechanistic immune-oncology model covering exhaustion, PD\u20111/PD\u2011L1 and antigen escape.", "area": "Immuno-oncology", "tag": "MODEL", "tier": "Open + Subscription", "status": "Publication-linked model page", "page": "models/car-t.html", "features": [ "T-cell expansion and tumour killing", "Exhaustion and checkpoint feedback", "Antigen escape and combination hypotheses" ], "free": [ "Model card and publication link" ], "paid": [ "Calibrated virtual populations", "Combination simulations" ] }, { "id": "glp1-ageing", "title": "GLP\u20111 / Semaglutide Ageing QSP", "short": "Weight, HbA1c, nausea and ageing-state model for GLP\u20111 therapies.", "area": "Metabolic", "tag": "MODEL", "tier": "Open + Subscription", "status": "Repository links pending", "page": "models/glp1-ageing.html", "features": [ "PK/PD and metabolic endpoints", "Ageing-state modifiers", "Nausea tolerability module" ], "free": [ "Model description and manuscript link" ], "paid": [ "Parameterised model and GSA outputs" ] }, { "id": "epo-erythropoiesis", "title": "EPO / ESA Erythropoiesis Digital Twin", "short": "ESA response model with erythropoiesis, miR\u2011486, mTOR, HIF\u2011PHI and SUMO recycling hooks.", "area": "Haematology", "tag": "MODEL", "tier": "Subscription", "status": "SBML pending", "page": "models/epo-erythropoiesis.html", "features": [ "Hb response dynamics", "ESA optimisation", "HIF\u2011PHI perturbation scenarios" ], "free": [ "Model description" ], "paid": [ "Digital twin layer" ] }, { "id": "aspirin-cox1", "title": "Aspirin COX\u20111 / TXB\u2082 / Resolvin QSP", "short": "ASA PK to irreversible COX\u20111 acetylation, TXB\u2082 turnover and aspirin-triggered resolvin branch.", "area": "Cardiovascular \u00b7 Inflammation", "tag": "DRAFT", "tier": "Open scaffold planned", "status": "SBML pending", "page": "models/aspirin-cox1.html", "features": [ "ASA PK and salicylate handling", "Irreversible COX\u20111 acetylation and platelet turnover", "TXB\u2082 inhibition and AT\u2011RvD1 extension" ], "free": [ "Draft model card and diagrams" ], "paid": [ "Formulation PK/PD and DDI simulations" ] }, { "id": "asthma-cytocon", "title": "Asthma CYTOCON\u2013EHMN2026 Neural\u2011ODE QSP", "short": "Genome-scale immunometabolic asthma model integrating CYTOCON DB, EHMN2026 and neural ODE surrogates.", "area": "Respiratory \u00b7 Immunology", "tag": "POSTER", "tier": "Open + Subscription", "status": "Poster/manuscript draft", "page": "models/asthma-cytocon.html", "features": [ "CYTOCON immune-cell/cytokine priors", "EHMN2026 metabolic bridge metabolites", "Neural ODE surrogate for virtual populations" ], "free": [ "Poster-style summary" ], "paid": [ "Population-scale calibrated simulation" ] }, { "id": "anaesthetics-pkpd", "title": "Integrated Anaesthetic PK/PD Combo Model", "short": "Propofol, sevoflurane and xenon model linking PK, receptor mechanisms, BIS, MAP, ventilation and recovery risks.", "area": "Anaesthesia \u00b7 CNS", "tag": "DRAFT", "tier": "Subscription research", "status": "SBML pending", "page": "models/anaesthetics-pkpd.html", "features": [ "Propofol TCI and gas-agent PBPK", "GABA, K2P, HCN and NMDA modules", "BIS, MAP, VentDrive, nausea and delirium proxies" ], "free": [ "Model card and mechanism diagram" ], "paid": [ "Controller simulations and safety scenarios" ] }, { "id": "glp1-ageing-v4-2-20260524-1030Z", "title": "GLP\u20111 / Semaglutide Ageing QSP v4.2 (20260524-1030Z)", "short": "Timestamped v4.2 recalibrated GLP\u20111 ageing model release added from uploaded ATLAS bundle; base GLP\u20111 page preserved.", "area": "Metabolic \u00b7 Ageing \u00b7 Obesity", "tag": "VERSIONED", "tier": "Open + Subscription", "status": "Timestamped v4.2 release added 2026-05-24T10:30:21Z", "page": "models/glp1-ageing-v4-2-20260524-1030Z.html", "parent_model": "glp1-ageing", "release_id": "glp1_v4_2_20260524_1030Z", "build_timestamp_utc": "2026-05-24T10:30:21Z", "features": [ "SBML v4.2 recalibrated release archived with SHA-256 manifest", "CSV outputs for species, parameters, calibration, trajectories, GSA, Bayesian meta-analysis and QC", "Preprint, supplementary documents and source bundle retained as timestamped artefacts", "Designed for future quarterly comparison without overwriting older releases" ], "free": [ "Timestamped model page", "SBML XML v4.2", "CSV data tables", "Release manifest and source bundle archive" ], "paid": [ "Quarterly GLP-1 evidence refreshes", "Partner-specific calibration and virtual population scenarios", "Regulatory-ready V&V documentation and COU refinement", "Combination optimisation and dashboard deployment" ], "downloads": [ [ "SBML v4.2", "../sbml/glp1/versions/glp1_v4_2_20260524_1030Z/IQANOVA_GLP1_Ageing_QSP_v4_2_recalibrated_20260524-1030Z.xml" ], [ "Release manifest", "../data/glp1/versions/glp1_v4_2_20260524_1030Z/glp1_v4_2_20260524_1030Z_manifest.json" ], [ "Source bundle", "../downloads/glp1/versions/glp1_v4_2_20260524_1030Z/IQANOVA_GLP1_ATLAS_Bundle_original_20260524-1030Z.zip" ] ] } ]